Balraj Singh

2.4k total citations
71 papers, 2.0k citations indexed

About

Balraj Singh is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Balraj Singh has authored 71 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 24 papers in Oncology and 18 papers in Genetics. Recurrent topics in Balraj Singh's work include Cancer Cells and Metastasis (13 papers), Estrogen and related hormone effects (11 papers) and Inflammatory mediators and NSAID effects (11 papers). Balraj Singh is often cited by papers focused on Cancer Cells and Metastasis (13 papers), Estrogen and related hormone effects (11 papers) and Inflammatory mediators and NSAID effects (11 papers). Balraj Singh collaborates with scholars based in United States, India and Switzerland. Balraj Singh's co-authors include Anthony Lucci, Jacob A. Berry, Ralph B. Arlinghaus, Angela Shoher, Laura Vincent, Massimo Cristofanilli, Asis Datta, Kendra R. Cook, Vijay R. Ramakrishnan and Savitri Krishnamurthy and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Balraj Singh

71 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Balraj Singh United States 24 989 824 426 328 297 71 2.0k
Desheng Lu China 25 1.9k 1.9× 723 0.9× 297 0.7× 294 0.9× 157 0.5× 68 2.8k
Margaret A. Park United States 28 1.4k 1.4× 574 0.7× 164 0.4× 310 0.9× 94 0.3× 55 2.1k
Nai Yang Fu Singapore 26 1.5k 1.5× 920 1.1× 390 0.9× 206 0.6× 62 0.2× 43 2.3k
Hsiang Fu Kung Hong Kong 28 900 0.9× 511 0.6× 216 0.5× 150 0.5× 109 0.4× 39 1.7k
Charles M. McGrath United States 19 1.3k 1.4× 967 1.2× 410 1.0× 623 1.9× 40 0.1× 31 2.3k
Bhuvanesh Dave United States 24 1.3k 1.3× 1.3k 1.5× 442 1.0× 141 0.4× 65 0.2× 39 2.6k
Steven Grant United States 24 1.2k 1.2× 794 1.0× 190 0.4× 505 1.5× 70 0.2× 35 2.1k
G. H. Heppner United States 22 690 0.7× 845 1.0× 465 1.1× 240 0.7× 45 0.2× 47 1.8k
Sarah Kraus Israel 19 642 0.6× 344 0.4× 196 0.5× 402 1.2× 82 0.3× 69 1.6k
Hongxia Zhu China 33 1.9k 1.9× 655 0.8× 756 1.8× 133 0.4× 98 0.3× 110 2.9k

Countries citing papers authored by Balraj Singh

Since Specialization
Citations

This map shows the geographic impact of Balraj Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balraj Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balraj Singh more than expected).

Fields of papers citing papers by Balraj Singh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Balraj Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balraj Singh. The network helps show where Balraj Singh may publish in the future.

Co-authorship network of co-authors of Balraj Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Balraj Singh. A scholar is included among the top collaborators of Balraj Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Balraj Singh. Balraj Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Singh, Balraj, et al.. (2022). Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor. Cancers. 14(11). 2631–2631. 2 indexed citations
3.
Addanki, Sridevi, et al.. (2022). Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers. International Journal of Molecular Sciences. 23(14). 7843–7843. 28 indexed citations
4.
Singh, Balraj, et al.. (2014). Highly Adaptable Triple-Negative Breast Cancer Cells as a Functional Model for Testing Anticancer Agents. PLoS ONE. 9(10). e109487–e109487. 14 indexed citations
5.
Gainer, Sarah M., Anirban Bhattacharyya, Ashutosh Lodhi, et al.. (2011). P4-07-11: Circulating Tumor Cells after Neoadjuvant Therapy Predict Outcome in Stage I to III Breast Cancer.. Cancer Research. 71(24_Supplement). P4–7. 1 indexed citations
6.
Singh, Balraj, et al.. (2010). Role of COX-2 in Tumorospheres Derived from a Breast Cancer Cell Line. Journal of Surgical Research. 168(1). e39–e49. 53 indexed citations
7.
Zhang, Dongwei, Tiffany A. LaFortune, Savitri Krishnamurthy, et al.. (2009). Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer. Clinical Cancer Research. 15(21). 6639–6648. 98 indexed citations
8.
Cook, Kendra R., Balraj Singh, Laura Vincent, et al.. (2008). 41. Cyclooxygenase-2 Induces Genomic Instability, BCL2 Expression, Doxorubicin Resistance, and Altered Cancer Initiating Cell Phenotype in MCF7 Breast Cancer Cells. Journal of Surgical Research. 144(2). 193–194. 3 indexed citations
9.
Lucci, Anthony, Savitri Krishnamurthy, Balraj Singh, et al.. (2008). Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Research and Treatment. 117(1). 61–68. 32 indexed citations
10.
Lang, Julie E., Massimo Cristofanilli, Savitri Krishnamurthy, et al.. (2008). HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Research and Treatment. 113(3). 501–507. 69 indexed citations
11.
Singh, Balraj, Laura Vincent, Jacob A. Berry, Asha S. Multani, & Anthony Lucci. (2007). Cyclooxygenase-2 Expression Induces Genomic Instability in MCF10A Breast Epithelial Cells. Journal of Surgical Research. 140(2). 220–226. 16 indexed citations
12.
Singh, Balraj, Jacob A. Berry, Laura Vincent, & Anthony Lucci. (2006). Involvement of IL-8 in COX-2-Mediated Bone Metastases from Breast Cancer. Journal of Surgical Research. 134(1). 44–51. 64 indexed citations
13.
Liu, Hui, et al.. (1999). Evidence of an interaction between Mos and Hsp70: a role of the Mos residue serine 3 in mediating Hsp70 association. Oncogene. 18(23). 3461–3470. 17 indexed citations
14.
Yang, Yandan, Christine Herrmann, Ralph B. Arlinghaus, & Balraj Singh. (1996). Inhibition of v-Mos Kinase Activity by Protein Kinase A. Molecular and Cellular Biology. 16(3). 800–809. 15 indexed citations
15.
Ciccarelli, Richard B., Laurie A. Winter, T. R. Bailey, et al.. (1994). Inhibition of the Cellular Rev Response and HIV-1 Replication by 8-Alkyl-2-(4-pyridyl)pyrido[2,3-d pyrimidin-5(8H)-Ones. Antiviral chemistry & chemotherapy. 5(3). 169–175. 6 indexed citations
16.
Bai, Wenlong, Ralph B. Arlinghaus, & Balraj Singh. (1993). Association of v-Mos with soluble vimentin in vitro and in transformed cells.. PubMed. 8(8). 2207–12. 9 indexed citations
17.
Singh, Balraj & Ralph B. Arlinghaus. (1992). The mos proto‐oncogene product: Its role in oocyte maturation, metaphase arrest, and neoplastic transformation. Molecular Carcinogenesis. 6(3). 182–189. 8 indexed citations
18.
Roy, Linda, Balraj Singh, Jean Gautier, et al.. (1990). The cyclin B2 component of MPF is a substrate for the c-mosxe proto-oncogene product. Cell. 61(5). 825–831. 95 indexed citations
19.
Singh, Balraj & Ralph B. Arlinghaus. (1989). Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells. Virology. 173(1). 144–156. 30 indexed citations
20.
Singh, Balraj, et al.. (1988). p37(mos) encoded by the HT-1 strain of Moloney murine sarcoma virus has an associated protein kinase activity. Oncogene. 3(1). 79–85. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Desheng Lu Breakdown of academic impact, for papers by Margaret A. Park Breakdown of academic impact, for papers by Nai Yang Fu Breakdown of academic impact, for papers by Hsiang Fu Kung Breakdown of academic impact, for papers by Charles M. McGrath Breakdown of academic impact, for papers by Bhuvanesh Dave Breakdown of academic impact, for papers by Steven Grant Breakdown of academic impact, for papers by G. H. Heppner Breakdown of academic impact, for papers by Sarah Kraus Breakdown of academic impact, for papers by Hongxia Zhu
Rankless by CCL
2026